Showing 6,009 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Hepatitis C symptoms & diagnosis

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

News
17 August 2017
Changing treatment

Terrence Higgins Trust and BHIVA advise on the use of generic HIV antiretroviral therapy

Editor's pick
Terrence Higgins Trust
16 August 2017
Changing treatment

Switch from boosted protease inhibitor to dolutegravir reduces lipids in people with HIV at higher risk of heart disease

News
9 August 2017
New & experimental HIV treatments

Boosted darunavir plus lamivudine matches three-drug regimen

News
8 August 2017
The search for a cure

VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

News
2 August 2017
New & experimental HIV treatments

Long-acting NRTI shows promise for HIV treatment and PrEP

News
2 August 2017
New & experimental HIV treatments

First protease inhibitor combination pill maintains viral suppression

News
1 August 2017
Resistance

A massive second global wave of AIDS is coming — perhaps within the next 10 years

Editor's pick
Business Insider
31 July 2017
PrEP programmes & uptake

Dutch study finds out whether gay men prefer daily or on-demand PrEP

News
28 July 2017
Side effects

New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment

Editor's pick
Napo Pharmaceuticals press release
27 July 2017
New & experimental HIV treatments

Doravirine combination pill looks good for initial HIV treatment

News
27 July 2017
Side effects

Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

News
27 July 2017
Transgender people

Drug interaction concerns may negatively affect HIV treatment adherence among transgender women

Editor's pick
NIAID
25 July 2017
Treatment for women

Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

News
25 July 2017
Starting treatment

New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

News
25 July 2017
Undetectable viral load & treatment as prevention

International study of gay couples reports no transmissions from an HIV-positive partner on treatment

News
25 July 2017
New & experimental HIV treatments

New integrase inhibitor bictegravir works well for first-line HIV treatment

News
25 July 2017
Improving HIV care

Less frequent clinic visits for HIV care: fine tuning needed

News
24 July 2017
Undetectable viral load & treatment as prevention

Swaziland: new infections halved in five years as HIV treatment scales up

News
24 July 2017
New & experimental HIV treatments

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

News
24 July 2017
Starting treatment

Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

Editor's pick
World Health Organization
23 July 2017
New & experimental HIV treatments

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

Editor's pick
Business Wire
21 July 2017
Side effects

Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects

News
21 July 2017
Resistance

WHO urges action against HIV drug resistance threat

Editor's pick
World Health Organization
20 July 2017